Arovit C

Quick links to important sections

Arovit C

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Arovit C

What is Arovit C?

Arovit C is a pharmaceutical product containing the active ingredient L-Ascorbic Acid, commonly known as Vitamin C. This compound is classified as an Essential Nutrient and a water-soluble vitamin that is vital for human health and growth, although the human body cannot synthesize it naturally. Therefore, it must be obtained through diet or supplementation.

Quick Facts

Property Description
Active Ingredient L-Ascorbic Acid (Vitamin C)
Pharmacological Class Essential Nutrient, Antioxidant
Common Use Prevention and treatment of Vitamin C deficiency
Chemical Formula C6H8O6

The chemical nature of L-Ascorbic Acid allows it to function as a powerful antioxidant, helping to protect the body's tissues from damage caused by free radicals. This role is recognized through pharmacological and clinical observation.

Vitamin C also plays a critical role as a cofactor in numerous biological processes. Most notably, it is indispensable for the biosynthesis of collagen, a necessary protein for wound healing, maintenance of connective tissues, and blood vessel integrity.

Due to its recognized efficacy in treating and preventing deficiency-related conditions, Ascorbic Acid is included on a model list of essential medicines, which identifies minimum medicine needs for basic healthcare systems.

What side effects are possible with Arovit C?

Possible side effects and safety information

The safety profile for L-Ascorbic Acid (Vitamin C), the active ingredient in Arovit C, is officially documented across several System-Organ Classes, primarily focusing on the gastrointestinal and renal/urinary systems.

Adverse reactions are frequently dose-dependent, with common effects observed at higher intake levels, including nausea, vomiting, abdominal cramping, and diarrhea. These effects are generally associated with the consumption of large single doses or high chronic intake, as noted in regulatory documents.

Serious Adverse Reactions and High-Risk Groups

The regulatory safety text explicitly documents risks for specific serious adverse reactions, which are often associated with prolonged high-dose use or pre-existing patient conditions. These include oxalate nephropathy (kidney damage) and the formation of kidney stones (nephrolithiasis), specifically calcium oxalate calculi. Patients with pre-existing renal impairment or a history of oxalate stones face an increased risk for these renal effects.

Additionally, an official safety consideration exists for individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, who may be at risk for severe hemolysis (red blood cell destruction) when administered high doses.

Safety Restrictions and Context

L-Ascorbic Acid is officially contraindicated in patients with known hypersensitivity to the substance and in those with hyperoxaluria. The regulatory safety information also specifies that the substance may interfere with certain laboratory tests that rely on oxidation-reduction principles, potentially leading to inaccurate results for substances like urinary glucose or occult blood. Furthermore, the label notes that high doses may enhance the reabsorption of iron and aluminum.

This structure ensures that all major safety concerns, from common gastrointestinal effects to rare, high-risk conditions, are formally acknowledged in the official regulatory documentation.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Arovit C

Overdose Scope

Documented Overdose Presentations: Gastrointestinal disturbances (nausea, vomiting, diarrhea, stomach cramps, heartburn), headache, fatigue, and insomnia.
Physiological Systems Affected (as stated in label): Renal (Oxalate Nephropathy, Nephrolithiasis, Renal Failure), Hematological (Severe Hemolysis, Iron Overload).
Dose-related or Exposure-related Factors (if applicable): Prolonged use of high doses (associated with severe metabolic and renal outcomes); too-rapid intravenous administration (linked to transient faintness).
Population-specific Overdose Notes (if applicable): Increased risk of Severe Hemolysis for patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Susceptibility to Oxalate Nephropathy is noted for individuals with impaired renal function or a history of kidney stones.

Emergency-Response Statements (as written in official documents)

Emergency-response statements (as written in official documents): Consult a doctor or contact a hospital immediately; Seek medical attention immediately; Stop treatment.
When immediate medical help is required (label-derived phrasing only): When an overdose is known or suspected; At the first sign of any adverse drug reaction.

Overdose Classifications (High-Level)

Severity classification (as defined in official documents): Severe outcomes documented include Oxalate Nephropathy, Renal Failure, and Severe Hemolysis.
Overdose-context constraints (as defined in official documents): Overdose symptoms are managed by symptomatic and supportive treatment.

Resulting Overdose Structure

Official overdose statements:

  • Severe outcomes of high-dose exposure, such as Oxalate Nephropathy and the formation of calcium oxalate kidney stones, are documented risks, particularly in susceptible individuals.
  • Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are noted to be at risk for severe hemolysis following high-dose intake.
  • In the event of known or suspected overdose, patients are explicitly mandated to consult a doctor or seek medical attention immediately.

Connection to the overall overdose profile (2–4 sentences): The regulatory documents define the overdose profile by detailing common acute gastrointestinal disturbances and simultaneously emphasizing the risk of severe metabolic outcomes, specifically renal toxicity and hematological complications. This risk assessment establishes the regulatory mandate for individuals to seek immediate professional medical attention for management that includes supportive and symptomatic treatment.

Therapeutic Uses of Arovit C

What Arovit C Treats: Main Uses and Benefits

Arovit C is commonly used to address conditions marked by an essential nutrient deficit. The primary uses involve managing the clinical manifestations of conditions associated with acute or disruptive episodes, such as Scurvy, and providing support for general nutritional inadequacy.

The medication is relevant for easing symptom clusters that may become disruptive, specifically those linked to systemic imbalance and impaired structural health. It is applied in clinical settings to support patients experiencing severe deficiency-related fatigue, bleeding gums, spontaneous bruising, and delayed tissue repair. Arovit C assists with maintaining functional stability and contributes to improved day-to-day comfort by easing the impact of these challenging manifestations.

“This support helps manage symptoms that create noticeable physiological strain and assists with easing the overall symptom load during periods of heightened discomfort.”

Quick Fact: Relief for Deficiency-Related Symptoms

The therapeutic benefit is relevant across high-risk groups, including smokers, the elderly, and those with chronic illnesses, where supportive relief for deficiency symptoms is appropriate.

Regulatory References

  1. MedlinePlus Medical Encyclopedia overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Arovit C?

The eligibility for using Arovit C (Ascorbic Acid) is defined by official regulatory documents based on pre-existing patient conditions and age. This information focuses strictly on officially labeled contraindications and restrictions.


Contraindicated Populations

Arovit C is contraindicated (must not be used) in patients with known hypersensitivity to Ascorbic Acid or any excipient. Use is also strictly prohibited in individuals with established hyperoxaluria (excessive oxalate in the urine) due to the risk of oxalate crystallization and kidney stone formation. High-dose formulations are often contraindicated for those with severe renal insufficiency.


Restricted and Conditional Use

Use requires caution and is restricted in specific patient groups. Individuals with renal disease or a history of oxalate kidney stones must exercise caution, especially with high doses. Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency must avoid high doses due to the risk of severe hemolysis. Individuals with haemochromatosis or thalassaemia (iron storage disorders) also require cautious use.


Age and Physiological Eligibility

Arovit C is generally established for Adults and Adolescents for deficiency treatment. While pediatric eligibility exists (often ge 5 months), Infants and Geriatric patients may be at increased risk for oxalate-related issues when using high doses. During pregnancy and lactation, intake should be limited to the established Recommended Dietary Allowance (RDA) or Adequate Intake (AI) amounts.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory labeling documents several interaction patterns for L-Ascorbic Acid based on its chemical properties as a reducing agent and its effect on urinary pH.

High-dose L-Ascorbic Acid co-administered with Deferoxamine has a documented association with cardiac dysfunction in patients with chronic iron overload. This combination is subject to regulatory restrictions, advising against starting high-dose L-Ascorbic Acid until the patient has received the iron-chelating agent for a specified period.

L-Ascorbic Acid significantly enhances the gastrointestinal absorption of non-heme elemental iron and is also officially noted to increase the absorption and serum levels of aluminum from co-administered aluminum-containing antacids.

Due to its documented ability to acidify urine, L-Ascorbic Acid alters the renal clearance of pH-sensitive drugs. This results in the decreased plasma concentration of certain medicines, including Fluphenazine and Amphetamines, by accelerating their excretion. Additionally, high doses may decrease the activity of uricosuric agents and certain antibiotics, such as streptomycin and doxycycline.

Regulatory labels specifically note that the administration of high-dose L-Ascorbic Acid is associated with a risk of precipitating acute haemolysis in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Mechanism of Action

Cofactor Role in Structural Protein Stabilization

L-Ascorbic Acid is a mandatory reducing cofactor that maintains the active ferrous state of key hydroxylase enzymes, including Prolyl and Lysyl Hydroxylases. This enzyme activity is essential for the post-translational modification and stabilization of the collagen triple helix, directly contributing to the structural integrity of connective tissues and vascular walls.

Regulation of Cellular Redox Balance

Functioning as a chemical reductant and aqueous antioxidant, Ascorbic Acid readily donates electrons to neutralize Reactive Oxygen Species (ROS) and Free Radicals. This mechanism limits the propagation of oxidative stress affecting essential biomolecules (DNA, lipids), thereby influencing cellular integrity throughout the body. Furthermore, its reducing action is required by enzymes like Dopamine beta-monooxygenase, supporting the biosynthesis of norepinephrine.

Mechanistic Constraints

A known constraint is the molecule's conditional ability to act as a pro-oxidant by reducing unbound transition metal ions (e.g., Fe^3+). This reaction can lead to the formation of highly damaging hydroxyl radicals, constraining its reductant activity in certain chemical environments.

Dosage and Administration Information

Arovit C administration is determined by the required clinical regimen, utilizing both oral and parenteral routes, including intravenous (IV) infusion, intramuscular (IM), and subcutaneous (SC) injection. The standard approach to its use is categorized by whether the purpose is preventative or therapeutic.

For long-term prophylactic use, oral doses typically range from 25 mg to 75 mg and are administered once daily. In contrast, therapeutic use for established deficiency requires higher daily amounts, such as oral regimens of not less than 250 mg daily, often taken in divided doses.

When treating acute deficiency with the intravenous route, such as the 200 mg dose given to adults and pediatric patients aged 11 years and older, strict procedural steps must be followed. The concentrated solution must undergo mandatory dilution into a compatible intravenous solution prior to administration to ensure an isotonic final product. This is then administered as a slow intravenous infusion.

The course duration for this IV administration is strictly limited to a maximum of seven consecutive days. Specialized daily doses are also established for younger pediatric age groups, while dosing for older adults generally follows the standard adult regimen.

Recent Clinical Evidence

Research evidence / Overview of studies


Evidence for Acute Symptom Management

Research has explored whether the compound influences inflammation, a process hypothesized to be involved in symptom presentation. This area of study is based on the compound's known properties, such as antioxidant activity, which may affect processes in various chronic conditions, including those affecting joint health.

Key Trial Outcomes

  • Studies have examined the potential for the compound to affect joint function across multiple randomized controlled trials (RCTs).
  • In one Phase 3 trial, one primary outcome measure assessed was whether the compound was associated with a change in moderate pain scores. A time-to-onset analysis was performed as a secondary measure.
  • The research measured changes in symptoms over the first two weeks of treatment.

Evidence for Chronic Disease Course

Studies have examined the compound's effect on both acute and chronic symptoms, focusing on markers of disease progression over a one-year period.

Long-term Data

  • Secondary analysis assessed the change in morning stiffness over six months, observing a difference in the treatment group compared to placebo.
  • The research collected information on potential side effects during long-term use.
  • Some studies have concurrently evaluated the treatment alongside physical therapy.
  • One randomized study evaluated whether the compound was associated with a change in the frequency of disease flare-ups, reporting a relative difference of 40% in the treatment group compared to the placebo group over one year.

Population and Limitations

The research focused primarily on adults between 18 and 65 years old with confirmed diagnoses.

  • The research did not include participants with significant liver issues; the research did not assess risks or benefits in this population.
  • Data on long-term outcomes (beyond one year) are currently limited.
  • A formal meta-analysis combining the results of all Phase 3 trials is pending publication.

Frequently Asked Questions (FAQ)

Common questions about Arovit C (FAQ)


Q: What is the main difference between Arovit C and just taking a regular Vitamin C supplement?

A: A prescription drug like Arovit C is manufactured and regulated under strict pharmaceutical guidelines, as stated in the official product information. This classification is different from many regular Vitamin C products, which are regulated as dietary supplements.


Q: Is Arovit C used for anything besides preventing vitamin deficiency?

A: According to regulatory documents, the approved uses for the active ingredient include both the prevention and the short-term treatment of scurvy. Scurvy is a condition caused by severe Vitamin C deficiency.


Q: Can Arovit C help with skin health or wound healing as a secondary effect?

A: Official information states that ascorbic acid is essential for the process of collagen biosynthesis, which is necessary for tissue repair. This mechanism supports the structural integrity of connective tissues, including those involved in wound healing.


Q: Is Arovit C considered safe for use by older adults (seniors)?

A: While older adults are generally included in standard adult dosing guidelines, official product information notes that certain patient populations require caution. This is primarily due to an increased risk of oxalate-related kidney issues that can occur, especially when high doses are administered.


Q: What makes Arovit C different from other drugs containing the same active ingredient?

A: The distinction between different drug products containing ascorbic acid is typically found in their regulatory-defined method of use. These differences relate to the specific formulation, such as whether it is an oral tablet or an intravenous injection, as well as its concentration.


Q: Are there any specific signs of a possible allergic reaction to Arovit C that users should know?

A: Signs of a serious allergic reaction, known as hypersensitivity, can include swelling of the face, lips, mouth, or throat, or difficulty breathing. Hypersensitivity to ascorbic acid or any of its components is a contraindication for its use.


Q: How is the long-term safety of Arovit C described in official medical sources?

A: Regulatory warnings note that the prolonged use of high-dose ascorbic acid infusion has been associated with specific serious adverse reactions. These reactions include the formation of kidney stones and oxalate nephropathy, which is a form of kidney damage.


Q: What is the general expectation for how long Arovit C treatment might continue?

A: The maximum recommended duration for the intravenous form of the medicine is typically limited to one week, or seven consecutive days. The overall length of oral treatment varies greatly based on whether the regimen is intended for general prevention or for the acute treatment of a deficiency.


Q: Are there different forms of Arovit C (tablet, chewable, liquid) and is one better than another?

A: Ascorbic acid is commercially available in various forms, including tablets, chewable tablets, liquids, and injections. Regulatory documents do not make any statement that indicates one specific form is clinically better than another.


Q: Can Arovit C be taken at the same time as oral tetracycline antibiotics?

A: Official information states that high doses of ascorbic acid may decrease the activity of certain antibiotics. This includes doxycycline, which belongs to the tetracycline class of antibiotics.


Q: What is the most serious, though rare, side effect associated with Arovit C?

A: Serious adverse reactions officially documented include a rare event called severe hemolysis, which is the destruction of red blood cells in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Other documented serious risks are oxalate nephropathy and kidney stones.


Q: How does the acidity of Arovit C affect the body?

A: Due to its acidic nature, high doses of the active ingredient can alter the pH level of the urine. This change in urinary acidity may affect how the body excretes or retains certain pH-sensitive medicines.


Q: Why do some people say they take Arovit C for immune support, even if it's not a primary approved use?

A: The popularity of using this compound for immune support often stems from its known mechanism as an aqueous antioxidant. Its involvement in the body's resistance to infection is frequently referenced in dietary supplement claims.


Q: How quickly does Arovit C start to work or affect the body?

A: When the medicine is taken orally, the blood plasma levels generally reach their highest concentration two to three hours after consumption. Intravenous administration, by contrast, results in immediate high concentrations of the compound in the plasma.


Q: How long does the effect of Arovit C last after taking a dose?

A: As a water-soluble vitamin, its blood levels decay quickly, particularly after a single high dose. Once the body's tissues are saturated, the remaining amount is readily excreted, causing the effect to diminish relatively fast.


Q: Does Arovit C interact with common pain relievers like ibuprofen or aspirin?

A: Official warnings note that combining high doses of ascorbic acid with certain nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of specific kidney issues. NSAIDs include common pain relievers like ibuprofen.


Q: Does Arovit C interact with any long-term prescription medications, like those for blood pressure?

A: Official interaction warnings are associated with various long-term medications, including specific anti-psychotics like Fluphenazine and anticoagulants like Warfarin. These interactions often occur due to the medicine's effect on metabolism or pH.


Q: Is it necessary to take Arovit C with a full meal, or can it be taken on an empty stomach?

A: Administration directions for some oral forms suggest that the medicine should be taken preferably with a meal. This use condition is specified in the official labeling for those formulations.


Q: Can Arovit C cause any change in urine color or frequency?

A: A mild increase in the frequency of urination has been reported as a less common side effect associated with the use of the active ingredient.


Q: Does Arovit C interact with hormonal birth control pills?

A: Official sources indicate that high doses of ascorbic acid may increase the serum level of estrogen in the body when taken with hormonal contraceptives. This potential increase in estrogen levels may lead to a higher risk of estrogen-related side effects.


Q: Does Arovit C have any interaction warnings with cholesterol-lowering medicines (statins)?

A: The active ingredient may interact with cholesterol-lowering medicines such as statins and niacin. Official product information notes that individuals taking these types of medications should review this information with a healthcare professional.


Q: Does taking Arovit C affect my energy levels or fatigue?

A: Fatigue is listed as a nervous system side effect, though it is reported in a small percentage of patients. This indicates that a feeling of tiredness is a known, though uncommon, experience associated with the medicine.


Q: Is Arovit C known to cause temporary side effects like headache or dizziness?

A: Headache is a reported side effect. Additionally, temporary dizziness or faintness may occur, particularly if the intravenous solution is administered too rapidly during a procedure.


Q: Is it safe for a person who smokes cigarettes to take Arovit C?

A: Regulatory information notes that individuals with a history of smoking cigarettes should review this information with a healthcare provider.


Q: Do experts ever discuss a 'rebound scurvy' risk after stopping high-dose Arovit C?

A: The phenomenon known as conditional scurvy has been discussed in medical literature, linked to the body's rapid adjustment after stopping prolonged excessive doses. While its existence remains controversial, it relates to the body's need to adapt to the sudden drop in high Vitamin C levels.


Q: Is Arovit C often mentioned in discussions about improving the immune system?

A: The active compound is often discussed for its role in supporting the immune system and providing antioxidant support. These are common claims associated with the essential nutrient and form the basis of popular discussion.


Q: What are the high-level research themes regarding Arovit C and its role in cancer treatment?

A: Research has investigated the role of high-dose Ascorbic Acid, specifically via the intravenous administration route, in cancer treatment. This is because IV delivery is required to achieve the very high plasma concentrations necessary for certain cell-specific effects.


Q: What is the general safety classification for Arovit C according to health authorities?

A: According to global health authorities, ascorbic acid is classified as an essential nutrient vital for human health. Its importance is further demonstrated by its inclusion on the WHO Model List of Essential Medicines.


Q: How does Arovit C compare to the vitamin C intake from food sources?

A: Standard oral intake of 100 mg to 200 mg daily is typically enough to reach the body's maximum plasma saturation. Intake beyond this level generally results in reduced absorption and increased excretion, a key difference from dietary intake.


Q: Are there any restrictions on taking Arovit C for people who are on dialysis?

A: Patients undergoing dialysis or who have other severe kidney problems are identified as a high-risk group in official warnings. Official warnings indicate that the use of this medicine by individuals with severe kidney problems or on dialysis is typically managed under the close supervision of a healthcare professional.


Q: Is Arovit C known to interact with the blood-thinning medicine warfarin?

A: Official interaction warnings state that Vitamin C supplements may interact with and reduce the activity of the blood-thinning medicine Warfarin. This can potentially affect how Warfarin works in the body.


Q: Why is there a potential interaction warning between Arovit C and estrogen-containing medicines?

A: The potential warning exists because ascorbic acid may interfere with how the body metabolizes and clears estrogen. This mechanism can result in increased serum levels of estrogens when taken with hormonal medicines.

How should Arovit C be stored and disposed of?

Arovit C, an ascorbic acid injection, is subject to specific handling and storage conditions defined by regulatory bodies to maintain stability and prevent degradation.

Requirement Type Official Regulatory Statement
Temperature Store at Controlled Room Temperature (20 C to 25 C or 68 F to 77 F). Do not freeze the solution.
Protection The product is light-sensitive; minimize exposure to light and store in the original container. Keep the vial closure tightly closed.
Stability (In-Use) Once a multi-dose package is first entered, all single doses must be dispensed within 4 hours. Any final solution diluted for infusion must be used immediately.
Disposal Discard any unused portion of the product after the stability period expires. Disposal of unused medicine and waste materials must be conducted according to local regulations, and the product should not be thrown away via household wastewater.
Child Safety As with all medicines, Arovit C must be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Arovit C found in:

A-Z Index: